Biopôle news

Horée Raises 330,000 Euros and continues Its Breakthrough in the Cosmetic Industry.
10 October 2024

Horée Raises 330,000 Euros and continues Its Breakthrough in the Cosmetic Industry.

Meet-up Pharma, a Day Dedicated to Health Industry Careers in Auvergne, will be Held on October 12th in Clermont-Ferrand.
26 September 2024

Meet-up Pharma, a Day Dedicated to Health Industry Careers in Auvergne, will be Held on October 12th in Clermont-Ferrand.

Greentech Acquires the Plant Extraction Activities of Laboratoire Gifrer.
24 September 2024

Greentech Acquires the Plant Extraction Activities of Laboratoire Gifrer.

Verdot invests 10 million euros at the Biopôle Clermont-Limagne.
23 September 2024

Verdot invests 10 million euros at the Biopôle Clermont-Limagne.

Eric Portier, new président of the Biopôle Clermont-Limagne Unrestricted Public Sector Association.
17 September 2024

Eric Portier, new président of the Biopôle Clermont-Limagne Unrestricted Public Sector Association.

Valbiotis to launch its 100% natural dietary supplement for the management of hypercholesterolemia on the French market in May.
5 April 2024

Valbiotis to launch its 100% natural dietary supplement for the management of hypercholesterolemia on the French market in May.

Alphanosos announces international partnership with Eurofragance.
30 November 2023

Alphanosos announces international partnership with Eurofragance.

“Accelerate your plant innovation!” VEGEPOLYS VALLEY launches the 8th edition of its contest dedicated to startups.
22 September 2023

“Accelerate your plant innovation!” VEGEPOLYS VALLEY launches the 8th edition of its contest dedicated to startups.

ONCOSEMA EST LAURÉATE DU CONCOURS DE L'INNOVATION I-LAB.
10 July 2023

ONCOSEMA EST LAURÉATE DU CONCOURS DE L’INNOVATION I-LAB.

Sabi Agri launches ZILUS, its 100% electric oll-terrain robot.
4 July 2023

Sabi Agri launches ZILUS, its 100% electric oll-terrain robot.

Valbiotis annonce le large succès de l’étude clinique de Phase II/III internationale multicentrique REVERSE-IT sur TOTUM•63 qui démontre son efficacité sur le principal facteur de risque du diabète de type 2.
23 May 2023

Valbiotis annonce le large succès de l’étude clinique de Phase II/III internationale multicentrique REVERSE-IT sur TOTUM•63 qui démontre son efficacité sur le principal facteur de risque du diabète de type 2.

The Riom La Varenne pharmaceutical site is part of the SMO Biopôle Clermont-Limagne for now 10 years.
17 April 2023

The Riom La Varenne pharmaceutical site is part of the SMO Biopôle Clermont-Limagne for now 10 years.

The SMO Biopôle Clermont-Limagne publishes its panorama and key figures for 2022.
17 March 2023

The SMO Biopôle Clermont-Limagne publishes its panorama and key figures for 2022.

Inauguration of the new Carbogen AMCIS production unit on the Biopôle Clermont-Limagne.
6 February 2023

Inauguration of the new Carbogen AMCIS production unit on the Biopôle Clermont-Limagne.

SABI AGRI raises €8 million to become a leader in agroecological robotics.
6 January 2023

SABI AGRI raises €8 million to become a leader in agroecological robotics.

Intestinal microbiota: Valbiotis Research signes a research partnership with the MEDIS2 Unit from the Clermont Auvergne University.
15 December 2022

Intestinal microbiota: Valbiotis Research signes a research partnership with the MEDIS2 Unit from the Clermont Auvergne University.

It is good to live and work at Biopôle Clermont-Limagne!
13 December 2022

It is good to live and work at Biopôle Clermont-Limagne!

“Accelerate your plant innovation!” VEGEPOLYS VALLEY is launching the 7th edition of its competition dedicated to start-ups.
3 October 2022

“Accelerate your plant innovation!” VEGEPOLYS VALLEY is launching the 7th edition of its competition dedicated to start-ups.

MEET-UP Pharma: the 1st forum of the Healthcare Industry Professions in Auvergne.
22 September 2022

MEET-UP Pharma: the 1st forum of the Healthcare Industry Professions in Auvergne.

Hypercholesterolemia: Valbiotis announces the major success of the Phase II HEART clinical study.
14 June 2022

Hypercholesterolemia: Valbiotis announces the major success of the Phase II HEART clinical study.

ON-LIGHT will take part on the 2nd Regional Research Days in the Hospital Centre, organized by Emile Roux Hospital Center of Puy-en-Velay on 23 and 24 June 2022.
9 June 2022

ON-LIGHT will take part on the 2nd Regional Research Days in the Hospital Centre, organized by Emile Roux Hospital Center of Puy-en-Velay on 23 and 24 June 2022.

Clermont Innovation Week Roundtable: How can and should health and climate-conscious agricultural approaches create value in our territories?
5 April 2022

Clermont Innovation Week Roundtable: How can and should health and climate-conscious agricultural approaches create value in our territories?

Le SMO Biopôle Clermont-Limagne publie son Panorama & chiffres Clés 2021.
1 April 2022

Le SMO Biopôle Clermont-Limagne publie son Panorama & chiffres Clés 2021.

Valbiotis announces approval to launch the two Phase II/III INSIGHT and INSIGHT 2 clinical studies, the last step in the development of TOTUM•854 for the reduction of blood pressure.
14 February 2022

Valbiotis announces approval to launch the two Phase II/III INSIGHT and INSIGHT 2 clinical studies, the last step in the development of TOTUM•854 for the reduction of blood pressure.

The EIB, with the support of the European Commission, is financing a €30 million loan for Carbios’ enzymatic recycling technology to support the Circular Economy.
21 December 2021

The EIB, with the support of the European Commission, is financing a €30 million loan for Carbios’ enzymatic recycling technology to support the Circular Economy.

STRAINCHEM enters the semi-industrial phase with France Relance.
17 December 2021

STRAINCHEM enters the semi-industrial phase with France Relance.

Carbios receives support from the European Commission through the LIFE program.
29 November 2021

Carbios receives support from the European Commission through the LIFE program.

Valbiotis: preclinical results for TOTUM•070 in hypercholesterolemia, selected and presented at the American Heart Association (AHA) annual meeting.
19 November 2021

Valbiotis: preclinical results for TOTUM•070 in hypercholesterolemia, selected and presented at the American Heart Association (AHA) annual meeting.

Pascal Mayer receives the prestigious breakthrough prize for his massive parallel sequencing technology codecovery.
11 October 2021

Pascal Mayer receives the prestigious breakthrough prize for his massive parallel sequencing technology codecovery.

Valbiotis obtains patent for its active substance TOTUM-63 in China.
25 May 2021

Valbiotis obtains patent for its active substance TOTUM-63 in China.

Carbios and Michelin on their way to 100% sustainable tires.
27 April 2021

Carbios and Michelin on their way to 100% sustainable tires.

With its extension project supported by France Relance, the Icare group strengthens its development ambitions.
12 April 2021

With its extension project supported by France Relance, the Icare group strengthens its development ambitions.

Discover BIOLIFE ENTERPRISES special Biopôle Clermont-Limagne
15 January 2021

Discover BIOLIFE ENTERPRISES special Biopôle Clermont-Limagne